Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Capital Employed (2016 - 2025)

Ptc Therapeutics has reported Return on Capital Employed over the past 13 years, most recently at 0.48% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.48% for Q4 2025, up 73.0% from a year ago — trailing twelve months through Dec 2025 was 0.48% (up 73.0% YoY), and the annual figure for FY2025 was 0.65%, up 90.0%.
  • Return on Capital Employed for Q4 2025 was 0.48% at Ptc Therapeutics, up from 0.44% in the prior quarter.
  • Over the last five years, Return on Capital Employed for PTCT hit a ceiling of 0.48% in Q4 2025 and a floor of 0.8% in Q3 2023.
  • Median Return on Capital Employed over the past 5 years was 0.25% (2021), compared with a mean of 0.17%.
  • Biggest five-year swings in Return on Capital Employed: plummeted -54bps in 2023 and later skyrocketed 74bps in 2025.
  • Ptc Therapeutics' Return on Capital Employed stood at 0.26% in 2021, then plummeted by -42bps to 0.36% in 2022, then decreased by -24bps to 0.45% in 2023, then skyrocketed by 44bps to 0.25% in 2024, then surged by 290bps to 0.48% in 2025.
  • The last three reported values for Return on Capital Employed were 0.48% (Q4 2025), 0.44% (Q3 2025), and 0.36% (Q2 2025) per Business Quant data.